Intrinsic Value of S&P & Nasdaq Contact Us

ViewRay, Inc. VRAY NASDAQ

NASDAQ Global Market • Healthcare • Medical - Devices • US • USD

SharesGrow Score
43/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$6.25
+24900%

Financial Health Score — VRAY

ViewRay, Inc. (VRAY) has an overall financial health rating of A- with a composite score of 0 out of 5.

This suggests the company faces some financial challenges worth monitoring. Rating as of 2023-08-21.

A-
Overall Rating
2023-08-21

Rating History

Date Rating DCF ROE ROA D/E P/E P/B
2023-08-21 A- -/5 -/5 -/5 -/5 -/5 -/5
2023-08-15 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-07-25 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-07-24 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-07-21 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-07-20 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-07-19 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-07-18 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-07-17 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-07-14 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-07-13 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-07-12 B+ -/5 -/5 -/5 -/5 -/5 -/5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message